Improving the first-line treatment of febrile illnesses in Ghana: willingness to pay for malaria rapid diagnostic tests at licensed chemical shops in the Kintampo area

Abstract Background Use of malaria rapid diagnostic test (mRDT) enhances patient management and reduces costs associated with the inappropriate use of antimalarials. Despite its proven clinical effectiveness, mRDT is not readily available at licensed chemical shops in Ghana. Therefore, in order to i...

Full description

Bibliographic Details
Main Authors: Theresa Tawiah, Keziah Malam, Anthony Kwarteng, Constance Bart-Plange, Lawrence Febir, Vivian Aubyn, Konrad Obermann, Seth Owusu-Agyei, Kwaku Poku Asante
Format: Article
Language:English
Published: BMC 2018-01-01
Series:Cost Effectiveness and Resource Allocation
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12962-018-0090-2
_version_ 1828473040234610688
author Theresa Tawiah
Keziah Malam
Anthony Kwarteng
Constance Bart-Plange
Lawrence Febir
Vivian Aubyn
Konrad Obermann
Seth Owusu-Agyei
Kwaku Poku Asante
author_facet Theresa Tawiah
Keziah Malam
Anthony Kwarteng
Constance Bart-Plange
Lawrence Febir
Vivian Aubyn
Konrad Obermann
Seth Owusu-Agyei
Kwaku Poku Asante
author_sort Theresa Tawiah
collection DOAJ
description Abstract Background Use of malaria rapid diagnostic test (mRDT) enhances patient management and reduces costs associated with the inappropriate use of antimalarials. Despite its proven clinical effectiveness, mRDT is not readily available at licensed chemical shops in Ghana. Therefore, in order to improve the use of mRDT, there is the need to understand the willingness to pay for and sell mRDT. This study assessed patients’ willingness to pay and licensed chemical operators’ (LCS) willingness to sell mRDTs. Methods The study was a cross-sectional survey conducted in Kintampo North Municipality and Kintampo South District of Ghana. Contingent valuation method using the dichotomous approach was applied to explore patient’s willingness to pay. In-depth interviews (IDIs) were used to obtain information from licensed chemical operators’ willingness to sell. Results Majority 161 (97%) of the customers were willing to pay for mRDT while 100% of licensed chemical operators were also willing to sell mRDT. The average lowest amount respondents were willing to pay was Ghana cedis (GH¢) 1.1 (US$ 0.26) and an average highest amount of GH¢ 2.1 (US$ 0.49). LCS operators were willing to sell the test kit at an average lowest price of GH¢1 (US$ 0.23) and average highest price of GH¢2 (US$ 0.47). Conclusion Community members were willing to pay for mRDT and LCS operators are willing to sell mRDTs. However, the high cost of the mRDT is likely to prevent the widespread use of mRDT. There is a clear need to find system-compatible ways to subsidize the use of mRDT via National Health Insurance scheme.
first_indexed 2024-12-11T05:38:34Z
format Article
id doaj.art-e9a9266933624c3188d70a0f91e71f6b
institution Directory Open Access Journal
issn 1478-7547
language English
last_indexed 2024-12-11T05:38:34Z
publishDate 2018-01-01
publisher BMC
record_format Article
series Cost Effectiveness and Resource Allocation
spelling doaj.art-e9a9266933624c3188d70a0f91e71f6b2022-12-22T01:19:12ZengBMCCost Effectiveness and Resource Allocation1478-75472018-01-011611910.1186/s12962-018-0090-2Improving the first-line treatment of febrile illnesses in Ghana: willingness to pay for malaria rapid diagnostic tests at licensed chemical shops in the Kintampo areaTheresa Tawiah0Keziah Malam1Anthony Kwarteng2Constance Bart-Plange3Lawrence Febir4Vivian Aubyn5Konrad Obermann6Seth Owusu-Agyei7Kwaku Poku Asante8Kintampo Health Research CenterNational Malaria Control Programme, Ghana Health ServiceKintampo Health Research CenterNational Malaria Control Programme, Ghana Health ServiceKintampo Health Research CenterNational Malaria Control Programme, Ghana Health ServiceMannheimer Institut of Public Health, Heidelberg UniversityKintampo Health Research CenterKintampo Health Research CenterAbstract Background Use of malaria rapid diagnostic test (mRDT) enhances patient management and reduces costs associated with the inappropriate use of antimalarials. Despite its proven clinical effectiveness, mRDT is not readily available at licensed chemical shops in Ghana. Therefore, in order to improve the use of mRDT, there is the need to understand the willingness to pay for and sell mRDT. This study assessed patients’ willingness to pay and licensed chemical operators’ (LCS) willingness to sell mRDTs. Methods The study was a cross-sectional survey conducted in Kintampo North Municipality and Kintampo South District of Ghana. Contingent valuation method using the dichotomous approach was applied to explore patient’s willingness to pay. In-depth interviews (IDIs) were used to obtain information from licensed chemical operators’ willingness to sell. Results Majority 161 (97%) of the customers were willing to pay for mRDT while 100% of licensed chemical operators were also willing to sell mRDT. The average lowest amount respondents were willing to pay was Ghana cedis (GH¢) 1.1 (US$ 0.26) and an average highest amount of GH¢ 2.1 (US$ 0.49). LCS operators were willing to sell the test kit at an average lowest price of GH¢1 (US$ 0.23) and average highest price of GH¢2 (US$ 0.47). Conclusion Community members were willing to pay for mRDT and LCS operators are willing to sell mRDTs. However, the high cost of the mRDT is likely to prevent the widespread use of mRDT. There is a clear need to find system-compatible ways to subsidize the use of mRDT via National Health Insurance scheme.http://link.springer.com/article/10.1186/s12962-018-0090-2MalariaMalaria RDTWillingness to payWillingness to sellKintampoGhana
spellingShingle Theresa Tawiah
Keziah Malam
Anthony Kwarteng
Constance Bart-Plange
Lawrence Febir
Vivian Aubyn
Konrad Obermann
Seth Owusu-Agyei
Kwaku Poku Asante
Improving the first-line treatment of febrile illnesses in Ghana: willingness to pay for malaria rapid diagnostic tests at licensed chemical shops in the Kintampo area
Cost Effectiveness and Resource Allocation
Malaria
Malaria RDT
Willingness to pay
Willingness to sell
Kintampo
Ghana
title Improving the first-line treatment of febrile illnesses in Ghana: willingness to pay for malaria rapid diagnostic tests at licensed chemical shops in the Kintampo area
title_full Improving the first-line treatment of febrile illnesses in Ghana: willingness to pay for malaria rapid diagnostic tests at licensed chemical shops in the Kintampo area
title_fullStr Improving the first-line treatment of febrile illnesses in Ghana: willingness to pay for malaria rapid diagnostic tests at licensed chemical shops in the Kintampo area
title_full_unstemmed Improving the first-line treatment of febrile illnesses in Ghana: willingness to pay for malaria rapid diagnostic tests at licensed chemical shops in the Kintampo area
title_short Improving the first-line treatment of febrile illnesses in Ghana: willingness to pay for malaria rapid diagnostic tests at licensed chemical shops in the Kintampo area
title_sort improving the first line treatment of febrile illnesses in ghana willingness to pay for malaria rapid diagnostic tests at licensed chemical shops in the kintampo area
topic Malaria
Malaria RDT
Willingness to pay
Willingness to sell
Kintampo
Ghana
url http://link.springer.com/article/10.1186/s12962-018-0090-2
work_keys_str_mv AT theresatawiah improvingthefirstlinetreatmentoffebrileillnessesinghanawillingnesstopayformalariarapiddiagnostictestsatlicensedchemicalshopsinthekintampoarea
AT keziahmalam improvingthefirstlinetreatmentoffebrileillnessesinghanawillingnesstopayformalariarapiddiagnostictestsatlicensedchemicalshopsinthekintampoarea
AT anthonykwarteng improvingthefirstlinetreatmentoffebrileillnessesinghanawillingnesstopayformalariarapiddiagnostictestsatlicensedchemicalshopsinthekintampoarea
AT constancebartplange improvingthefirstlinetreatmentoffebrileillnessesinghanawillingnesstopayformalariarapiddiagnostictestsatlicensedchemicalshopsinthekintampoarea
AT lawrencefebir improvingthefirstlinetreatmentoffebrileillnessesinghanawillingnesstopayformalariarapiddiagnostictestsatlicensedchemicalshopsinthekintampoarea
AT vivianaubyn improvingthefirstlinetreatmentoffebrileillnessesinghanawillingnesstopayformalariarapiddiagnostictestsatlicensedchemicalshopsinthekintampoarea
AT konradobermann improvingthefirstlinetreatmentoffebrileillnessesinghanawillingnesstopayformalariarapiddiagnostictestsatlicensedchemicalshopsinthekintampoarea
AT sethowusuagyei improvingthefirstlinetreatmentoffebrileillnessesinghanawillingnesstopayformalariarapiddiagnostictestsatlicensedchemicalshopsinthekintampoarea
AT kwakupokuasante improvingthefirstlinetreatmentoffebrileillnessesinghanawillingnesstopayformalariarapiddiagnostictestsatlicensedchemicalshopsinthekintampoarea